Identification of nm23-H1 as a metastatic suppressor and prognostic factor in nasopharyngeal carcinoma by proteomic analysis

Journal of Central South University (Medical Sciences)

Volumn 37, Issue 1, 2012, Pages 17-26

  Li, Xuebing ^a   Hu, Rong ^a   Qu, Jiaquan ^a   He, Qjuyan ^a   Yu, Chen ^a   Li, Jiaoyang ^a   Ye, Xu ^a   Xiang, Yali ^a   Yi, Hong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Metastasis; Nasopharyngeal carcinoma; Nm23 H1; Prognosis; Proteomics

Indexed keywords

NME1 PROTEIN, HUMAN; NUCLEOSIDE DIPHOSPHATE KINASE NM23; PROTEOME; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; GENETICS; HUMAN; MASS SPECTROMETRY; METABOLISM; METASTASIS; METHODOLOGY; NASOPHARYNX TUMOR; PATHOLOGY; PROGNOSIS; PROTEOMICS; TUMOR CELL LINE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

CELL LINE, TUMOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; MASS SPECTROMETRY; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; PROGNOSIS; PROTEOME; PROTEOMICS; TUMOR SUPPRESSOR PROTEINS;

EID: 84863252585     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-7347.2012.01.004     Document Type: Article

References (31)

1. Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma[J]. Semin Cancer Biol, 2002, 12(6): 421-429. (Pubitemid 35370755)
2. Ho JHC. An epidemiologic and clinical study of nasopharyngeal carcinoma[J]. IntJ Radiat Oncol Biol Phys, 1978, 4(3/4): 183-198. (Pubitemid 8338246)
3. King AD,Ahuja AT,Leung SF, et al. Neck node metastases from nasopharyngeal carcinoma: MR imaging of patterns of disease [J]. Head Neck, 2000, 22(3): 275-281. (Pubitemid 30215324)
4. Huang CJ, Leung SW, Lian SL, et al. Patterns of distant metastases in nasopharyngeal carcinoma[J]. Kaohsiung J Med Sci,1996, 12(4): 229-234.
5. Lee AW,Poon YF, Foo W, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overalI survival and patterns of failure[J]. Int J Radiat Oncol Biol Phys, 1992, 23(2): 261-270.
6. Leung SF, Teo PM, Shiu WW, et al. Clinical features and management of distant metastases of nasopharyngeal carcinoma[J].JOtolaryngol, 1991, 20(1): 27-29.
7. Lung HL, Bangarusamy DK, Xie D, et al. THYI is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma[J]. Oncogene,2005, 24(43): 6525-6532.
8. Fang WY, Liu TF, Xie WB, et al. Reexploring the possible roles of some genes associated with nasopharyngeal carcinoma using microarray-based detection[J]. Acta Biochim Biophys Sin (Shanghai), 200S, 37(8): 541-546.
9. Reymond MA,Schlegel W. Proteomics in cancer[J]. Adv Clin Chem, 2007, 44: 103-142.
10. Song LB,Yan J,Jian SW, et al. Molecular mechanisms of tumorgenesis and metastasis in nasopharyngeal carcinoma cell sublines[J]. Ai Zheng, 2002,21(2): 158-162.
11. Wu YT, Wang HM, Yang XP. Establishment and characterization of a xenografted nasopharyngeal carcinoma and corresponding epithelial cell line[J]. Ai Zheng, 1995, 14(3): 83-88.
12. Song LB,Wang HM,Zheng M. Study on the tumor heterogeneity of nasopharyngeal carcinoma cell line (SUNE-I)[J]-Ai Zheng, 1998, 17(2): 324-327.
13. Qian CN, Guo X, Cao B,et al. Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma[J], Cancer Res, 2002, 62(2): 589-S96.
14. Yang YX, Xiao ZQ, Chen ZC, et al. Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901 /VCR[J]. Proteomics, 2006, 6(6): 2009-2021.
15. Cheng AL, Huang WG, Chen ZC, et al. Identification of novel biomarkers for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis[J]. Clin Cancer Res,2008,14(2):43S-445.
16. Steeg PS, Bevilacqua G,Kopper L,et al. Evidence for a novel gene associated with low tumor metastatic potentialfj]. J Natl Cancer Inst, 1988, 80(3): 200-204.
17. Hartsough MT, Steeg PS. nm23/nucleoside diphosphate kinase in human cancers[J]. J Bioenerg Biomembr, 2000, 32(3): 301-308.
18. Almgren MA,Henriksson KC,Fujimoto J, et al. Nucleoside diphosphate kinase A/nm23-Hl promotes metastasis of NB69derived human neuroblastoma [J]. MoI Cancer Res, 2004, 2(7): 387-394 (Pubitemid 39031072)
19. Oda Y, Naka T, Takeshita M, et al. Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: a clinicopathologic and immunohistochemical study[J]. Hum Pathol, 2000, 3l(6): 709-716. (Pubitemid 30445475)
20. Nakamori S, Ishikawa 0, Ohhigashi H, et al. Expression of nucleoside diphosphate kinase/nm23 gene product in human pancreatic cancer: an association with lymph node metastasis and tumor invasion[J]. Clin Exp Metastasis,1993,11(2) : 151-158.
21. Wang LS, Chow KC, Lien YC, et al. Prognostic significance of nm23H1 expression in esophageal squamous cell carcinoma[J]. Eur J Cardiothorac Surg, 2004, 26(2):419-424.
22. Hennessy C, Henry JA, May FE, et al. Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis[J]. J Natl Cancer Inst, 1991, 83(4): 281-285.
23. Florenes VA.Aamdal S, Myklebost 0, et al. Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression[J]. Cancer Res,1992,52(21): 6088-6091.
24. Nakayama T,Ohtsuru A, Nakao K, et al. Expression in human hepatocellular carcinoma of nucleoside diphosphate kinase,a homologue of the nm23 gene product[J]. J Natl Cancer Inst, 1992, 84(17): 1349-13S4.
25. Hsu NY, Chow KC, Chen WJ, et al. Expression of nm23 in the primary tumor and the metastatic regional lymph nodes of patients with gastric cardiac cancer[J]. Clin Cancer Res, 1999, 5(7): 1752-1757.
26. Haut M, Steeg PS, Willson JK, et al. Induction of nm23 gene expression in human colonic neoplasms and equal expression in colon tumors of high and low metastatic potential[J]. J Natl Cancer Inst, 1991, 83 (10): 712-716.
27. Zou M, Shi Y, al-Sedairy S. High levels of nm23 gene expression in advanced stage of thyroid carcinomas[J]. Br J Cancer, 1993, 68(2): 38S-388.
28. Müller W,Schneiders A,Hommel G,et al. Expression of nm23 in gastric carcinoma: association with tumor progression and poor prognosis[J].Cancer,1998, 83(l2):2481-2487. (Pubitemid 29019566)
29. Pavelić K,Kapitanović S, Radosević S, et al. Increased activity of nm23-H1 gene in squamous cell carcinoma of the head and neck is associated with advanced disease and poor prognosis[J]. J Mol Med, 2000, 78(2): 111-118.
30. Niitsu N, Nakamine H, Okamoto M, et al. Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphomafj]. BrJ Haematol,2003, 123(4): 621-630. (Pubitemid 37468058)
31. Bosnar MH, Pavelic K, Krizanac S, et al. Squamous cell lung carcinomas: the role of nm23-Hl gene[J]. J Mol Med,1997,75(8): 609-613. (Pubitemid 27373604)